The IV STING agonist, TAK-676, enhances immune-mediated anti-tumor activity of radiation in syngeneic mouse models

被引：0
|
作者：
Appleman, Vicky A. [1 ]
Berger, Allison J. [1 ]
Roberts, Emily R. [1 ]
Maldonado-Lopez, Angel E. [1 ]
Ganno, Michelle L. [1 ]
Christensen, Camilla I. [1 ]
Hatten, Tiquella [1 ]
Sato, Yosuke [1 ]
Shaw, Michael H. [1 ]
Malek, Karim S. [1 ]
Lineberry, Neil B. [1 ]
Abu-Yousif, Adnan O. [1 ]
Gregory, Richard C. [1 ]
机构：
[1] Takeda Dev Ctr Amer Inc TDCA, Lexington, MA USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3448
引用
收藏
页数：1
相关论文
共 47 条
  • [1] Intratumoral microdosing via the CIVO® Platform reveals anti-tumor immune responses induced by the STING Agonist TAK-676 alone and in combination with chemotherapies
    Hatton, Beryl A.
    Grenley, Marc
    Ditzler, Sally
    Klinghoffer, Richard A.
    Berger, Allison J.
    Malek, Karim S.
    Gregory, Richard C.
    Lineberry, Neil B.
    CANCER RESEARCH, 2022, 82 (12)
  • [2] Radiation enhances anti-tumor activity of immune checkpoint blockade in syngeneic tumor models
    Urs, Sumithra
    Meade, Mary Anne
    Guley, Kevin
    Krueger, Sarah
    Wong, Alden
    Wise, Scott
    Franklin, Maryland
    CANCER RESEARCH, 2018, 78 (13)
  • [3] Preclinical assessment of anti-tumor activity and immune response in syngeneic tumor models
    Franklin, M.
    Thayer, M.
    Draper, D.
    Saims, D.
    Wise, S.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S97 - S97
  • [4] Reovirus combined with a STING agonist enhances anti-tumor immunity in a mouse model of colorectal cancer
    Sugimura, Naomi
    Kubota, Eiji
    Mori, Yoshinori
    Aoyama, Mineyoshi
    Tanaka, Mamoru
    Shimura, Takaya
    Tanida, Satoshi
    Johnston, Randal N. N.
    Kataoka, Hiromi
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (11) : 3593 - 3608
  • [5] Reovirus combined with a STING agonist enhances anti-tumor immunity in a mouse model of colorectal cancer
    Naomi Sugimura
    Eiji Kubota
    Yoshinori Mori
    Mineyoshi Aoyama
    Mamoru Tanaka
    Takaya Shimura
    Satoshi Tanida
    Randal N. Johnston
    Hiromi Kataoka
    Cancer Immunology, Immunotherapy, 2023, 72 : 3593 - 3608
  • [6] Inhibition of arginase in combination with radiation therapy shows increased immune-activation and anti-tumor activity in syngeneic tumor models.
    Schuller, Alwin
    Doshi, Aatman
    Cantin, Susan
    Griffin, Matt
    San Martin, Maryann
    Proia, Theresa
    Reimer, Corinne
    Mlynarski, Scott
    Finlay, Ray
    Shao, Wenlin
    CANCER RESEARCH, 2021, 81 (13)
  • [7] STING agonist cGAMP enhances anti-tumor activity of CAR-NK cells against pancreatic cancer
    Da, Yanyan
    Liu, Yuxia
    Hu, Yuan
    Liu, Wenzeng
    Ma, Junpeng
    Lu, Nan
    Zhang, Chengsheng
    Zhang, Cai
    ONCOIMMUNOLOGY, 2022, 11 (01):
  • [8] Combination with a novel STING agonist significantly improves efficacy of anti-PD1 therapy in mouse syngeneic tumor models
    Perera, Samanthi A.
    Kopinja, Johnny E.
    Ma, Yanhong
    Laskey, Jason
    Chakravarthy, Kalyan
    Cui, Long
    Chen, Yiping
    Presland, Jeremy
    Sharma, Sharad
    Zhao, Shuxia
    Piesvaux, Jennifer
    Minnihan, Ellen C.
    Ferguson, Heidi
    Woo, Hyun Chong
    Knemeyer, Ian
    Kariv, Ilona
    Tse, Archie
    Cemerski, Saso
    Cumming, Jared
    Trotter, B. Wesley
    Pan, Bo-Sheng
    Addona, George H.
    Long, Brian J.
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (09)
  • [9] AAV Mediated Expression of Mouse IL-12 Shows Potent Anti-Tumor Activity and Immune Response Alone and in Combination with Anti-PD1 in Syngeneic Murine Tumor Models
    Sutton, David
    Prentiss, Pilar
    Furmanski, Brian
    MOLECULAR THERAPY, 2022, 30 (04) : 161 - 161
  • [10] The PPAR Agonist Rosiglitazone Suppresses Syngeneic Mouse SCC (Squamous Cell Carcinoma) Tumor Growth through an Immune-Mediated Mechanism
    Konger, Raymond L.
    Derr-Yellin, Ethel
    Ermatov, Nurmukambed
    Ren, Lu
    Sahu, Ravi P.
    MOLECULES, 2019, 24 (11):
12345